76 related articles for article (PubMed ID: 2119409)
21. Ovarian cancer and gonadotropins in vitro: new evidence in favor of independence.
Ala-Fossi SL; Grenman S; Zhang FP; Bläuer M; Punnonen R; Mäenpää J
Anticancer Res; 1999; 19(5B):4289-95. PubMed ID: 10628389
[TBL] [Abstract][Full Text] [Related]
22. Investigation of binding sites for follicle-stimulating hormone and chorionic gonadotropin in human ovarian cancers.
Stouffer RL; Grodin MS; Davis JR; Surwit EA
J Clin Endocrinol Metab; 1984 Sep; 59(3):441-6. PubMed ID: 6086699
[TBL] [Abstract][Full Text] [Related]
23. Effect of gonadotropins on human endometrial stromal cell proliferation in vitro.
Ku SY; Choi YM; Suh CS; Kim SH; Kim JG; Moon SY; Lee JY
Arch Gynecol Obstet; 2002 Aug; 266(4):223-8. PubMed ID: 12192484
[TBL] [Abstract][Full Text] [Related]
24. [Responsiveness of gynecological malignancies to oral antitumor agents in subrenal capsule assay and individualization of oral adjuvant chemotherapy].
Sekiguchi I; Suzuki M; Aida I; Tamada T; Nishida M
Nihon Sanka Fujinka Gakkai Zasshi; 1990 May; 42(5):437-42. PubMed ID: 2115558
[TBL] [Abstract][Full Text] [Related]
25. LH analog and dietary isoflavones support ovarian granulosa cell tumor development in a spontaneous mouse model.
Dorward AM; Shultz KL; Beamer WG
Endocr Relat Cancer; 2007 Jun; 14(2):369-79. PubMed ID: 17639051
[TBL] [Abstract][Full Text] [Related]
26. [Subrenal capsule assay using nude mice].
Kikuchi H; Asamura M; Gamoh M; Ohuchi H; Wakui A
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):532-41. PubMed ID: 2321981
[TBL] [Abstract][Full Text] [Related]
27. [Experimental study of the 6-day subrenal capsule assay by cyclophosphamide pretreatment].
Terashima M; Ikeda K; Kawamura S; Satoh M; Ishida K; Amano K; Takagane A; Yaegashi Y; Saitoh K
Gan To Kagaku Ryoho; 1988 Mar; 15(3):505-11. PubMed ID: 3348636
[TBL] [Abstract][Full Text] [Related]
28. [Gonadotropins and ovarian cancer].
Nowak-Markwitz E; Jankowska A; Spaczyński M
Ginekol Pol; 2005 Feb; 76(2):153-62. PubMed ID: 15847084
[TBL] [Abstract][Full Text] [Related]
29. Human chorionic gonadotropin suppresses ovarian epithelial neoplastic cell proliferation in vitro.
Tourgeman DE; Lu JJ; Boostanfar R; Amezcua C; Felix JC; Paulson RJ
Fertil Steril; 2002 Nov; 78(5):1096-9. PubMed ID: 12414000
[TBL] [Abstract][Full Text] [Related]
30. Hormonal activity of epithelial ovarian tumours in post-menopausal women.
Heinonen PK; Mörsky P; Aine R; Koivula T; Pystynen P
Maturitas; 1988 Mar; 9(4):325-38. PubMed ID: 3380017
[TBL] [Abstract][Full Text] [Related]
31. Effects of antisense oligodeoxynucleotide to follicle-stimulating hormone receptor on the expression of proliferating cell nuclear antigen and vascular endothelial growth factor in primary culture cells derived from human ovarian mucinous cystadenocarcinoma.
Li S; Liu H; Wang L; Zhu C
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(1):111-5. PubMed ID: 16711022
[TBL] [Abstract][Full Text] [Related]
32. Gonadotropins, estradiol, and growth factors regulate epithelial ovarian cancer cell growth.
Wimalasena J; Dostal R; Meehan D
Gynecol Oncol; 1992 Sep; 46(3):345-50. PubMed ID: 1326473
[TBL] [Abstract][Full Text] [Related]
33. Gonadotropins and ovarian cancer.
Choi JH; Wong AS; Huang HF; Leung PC
Endocr Rev; 2007 Jun; 28(4):440-61. PubMed ID: 17463396
[TBL] [Abstract][Full Text] [Related]
34. [Evaluation of the subrenal capsule assay (SRCA) in breast cancer using immunocompetent (NIC) mice].
Gerber B; Richter D; Rohde E; Wilken H; Rudolf K; Kasch R
Zentralbl Gynakol; 1989; 111(14):952-9. PubMed ID: 2800779
[TBL] [Abstract][Full Text] [Related]
35. Localization of gonadotropin binding sites in human ovarian neoplasms.
Nakano R; Kitayama S; Yamoto M; Shima K; Ooshima A
Am J Obstet Gynecol; 1989 Oct; 161(4):905-10. PubMed ID: 2552807
[TBL] [Abstract][Full Text] [Related]
36. Role of gonadotropins in malignant progression of sex cord stromal tumors produced by sequential auto- and isogenic transplantation of ovarian tissue in ovariectomized rats.
Dittrich R; Recabarren S; Mitze M; Jaeger W
J Cancer Res Clin Oncol; 2001 Aug; 127(8):495-501. PubMed ID: 11501749
[TBL] [Abstract][Full Text] [Related]
37. Placental proteins (PP 5, PP 12 and PP 14) in ovarian tumors. A preliminary report.
Boltenberg A; Furgyik S
Acta Obstet Gynecol Scand; 1987; 66(3):213-5. PubMed ID: 3661128
[TBL] [Abstract][Full Text] [Related]
38. Establishment and characterization of a cell line (OMC-3) originating from a human mucinous cystadenocarcinoma of the ovary.
Yamada T; Ueda M; Otsuki Y; Ueki M; Sugimoto O
Gynecol Oncol; 1991 Feb; 40(2):118-28. PubMed ID: 2010102
[TBL] [Abstract][Full Text] [Related]
39. Gonadotropins and ovarian carcinogenesis: a new era of basic research and its clinical implications.
Konishi I
Int J Gynecol Cancer; 2006; 16(1):16-22. PubMed ID: 16445604
[TBL] [Abstract][Full Text] [Related]
40. Histologic correlates of virulence in ovarian adenocarcinoma. I. Effect of differentiation.
Jacobs AJ; Deligdisch L; Deppe G; Cohen CJ
Am J Obstet Gynecol; 1982 Jul; 143(5):574-80. PubMed ID: 7201242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
